Hashimoto’s Encephalopathy: An Unusual Cause of Autoimmune Encephalopathy in a Clinically and Biochemically Euthyroid Patient
  • Senthil Chandrasekaram
    Department of Endocrinology and Diabetes, King’s Mill Hospital, Sherwood Forest Hospital NHS Foundation Trust, Sutton-in-Ashfield
  • Emily Mudenha
    Department of Endocrinology and Diabetes, King’s Mill Hospital, Sherwood Forest Hospital NHS Foundation Trust, Sutton-in-Ashfield
  • Buddhike A Mendis
    Department of Endocrinology and Diabetes, King’s Mill Hospital, Sherwood Forest Hospital NHS Foundation Trust, Sutton-in-Ashfield
  • Antal Szabo
    Department of Endocrinology and Diabetes, King’s Mill Hospital, Sherwood Forest Hospital NHS Foundation Trust, Sutton-in-Ashfield
  • Devaka JS Fernando
    Department of Endocrinology and Diabetes, King’s Mill Hospital, Sherwood Forest Hospital NHS Foundation Trust, Sutton-in-Ashfield Department of Diabetes and Endocrinology, University of Sheffield, Sheffield Postgraduate Medical Centre, Sheffield Hallam University, Sheffield

Abstract

Objectives: To highlight the occurrence of Hashimoto’s encephalopathy – a steroid-responsive encephalopathy associated with elevated antithyroid antibodies.

Material and methods: We describe a clinically and biochemically euthyroid patient with an encephalopathy presenting with headache, mild confusion and personality changes for 6 weeks and tonic–clonic seizures upon admission

Results: There was no obvious infective or metabolic cause. The patient had a high titre of antithyroid antibodies and responded to steroid therapy.

Conclusion: This uncommon disease needs to be considered in patients presenting with neurological symptoms that remain unexplained after routine standard investigations, even when the patient is euthyroid. Early diagnosis is important, as this is a treatable condition.

VIEW THE ENTIRE ARTICLE

References

  • Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy: syndrome or myth? Arch Neurol 2003;60:164–171.
  • Ferracci F, Bertiato G, Moretto G. Hashimoto's encephalopathy: epidemiologic data and pathogenetic considerations, J Neurol Sci 2004;217:165–168.
  • Nieuwenhuis L, Santens P, Vanwallaeghem P, Boon P. Subacute Hashimoto’s encephalopathy, treated with plasmapheresis, Acta Neurol Belg 2004;104:80–83.
  • Fujii A, Yoneda M, Ito T, Yamamura O, Satomi S, Higa H et al. Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker of Hashimoto's encephalopathy, J Neuroimmunol 2005;162:130–136.
  • Rodrigez A, Jicha G, Steeves T, Benarroch E, Westmoreland B. EEG changes in a patient with steroid responsive encephalopathy associated with antibodies to thyroperoxidase (SREAT, Hashimoto's encephalopathy), J Clin Neurophysiol 2006;23:371–373.
  • Views: 1052
    HTML downloads: 409
    PDF downloads: 400
    Untitled downloads: 0
    Learning Points downloads: 0
    Revision as requested by reviewers downloads: 0


    Published: 2014-10-14
    Issue: Vol. 1 (2014) (view)


    How to cite:
    1.
    Chandrasekaram S, Mudenha E, Mendis BA, Szabo A, Fernando DJ. Hashimoto’s Encephalopathy: An Unusual Cause of Autoimmune Encephalopathy in a Clinically and Biochemically Euthyroid Patient. EJCRIM 2014;1 doi:10.12890/2014_000141.